• Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: Japan

Daiwa ETF TOPIX-17 Pharmaceutical

+ Add to Watchlist

1638:JP

15,910.0000 JPY 160.0000 1.02%

As of 01:26:20 ET on 10/24/2014.

Snapshot for Daiwa ETF TOPIX-17 Pharmaceutical (1638)

Open: 15,910.0000 High - Low: 15,910.0000 - 15,910.0000 Primary Exchange: Tokyo
Volume: 1 52-Week Range: 13,440.0000 - 16,640.0000 Beta vs TP17PHRM: 0.8912

ETF Chart for 1638

No chart data available.
  • 1638:JP 15,910.0000
  • 1D
  • 1M
  • 1Y
15,750.0000
Interactive 1638 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for 1638

Daiwa ETF TOPIX-17 PHARMACEUTICAL ETF is an exchange-traded fund incorporated i n Japan. The objective of the Fund is to provide investment results that c orrespond to the performance of the TOPIX-17 Pharmaceutical Index.

Inception Date: 2008-07-23 Telephone: -
Managers: -
Web Site: www.daiwa-am.co.jp

Fundamentals for 1638

NAV (on 2014-10-24) 15,979.0000
Assets (M) (on 2014-10-24) 451.0000
Shares out (M) 0.03
Market Cap (M) 448.79
% Premium -0.43
Average 52-Week % Premium -0.2359
Fund Leveraged N

Dividends for 1638

Dividend Type Distribution
Dividend Frequency Semi-Anl
Last Dividend Net (on 2014-07-16) 180.0000
Dividend Yield (ttm) 2.21%

Performance for 1638

1-Month -1.67% 1-Year +20.28%
3-Month +5.71% 3-Year +21.30%
Year To Date +9.89% 5-Year +11.24%
Expense Ratio 0.18

Top Fund Holdings for 1638

Filing Date: 09/30/2014
Name Position Value % of Total
Astellas Pharma Inc 62,000 101,246,000 21.867%
Takeda Pharmaceutical Co Ltd 20,400 97,267,200 21.008%
Otsuka Holdings Co Ltd 10,800 40,824,000 8.817%
Eisai Co Ltd 6,700 29,714,500 6.418%
Daiichi Sankyo Co Ltd 17,100 29,429,100 6.356%
Ono Pharmaceutical Co Ltd 2,500 24,350,000 5.259%
Shionogi & Co Ltd 8,500 21,386,000 4.619%
Chugai Pharmaceutical Co Ltd 5,400 17,145,000 3.703%
Santen Pharmaceutical Co Ltd 2,000 12,280,000 2.652%
Taisho Pharmaceutical Holdings 1,300 9,763,000 2.109%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil